Shares of BioCryst Pharmaceuticals Inc. BCRX, +0.00% and Idera Pharmaceuticals Inc. IDRA, -0.72% were active in the extended session Tuesday following a brief halt after BioCryst shareholders voted down a merger between the two drug companies. BioCryst shares rallied 7.5% after hours, following flat trade Tuesday to close at $6.14. Idera shares dropped 16% after hours, following a 0.7% decline to close the regular session at $1.37. BioCryst said it would reimburse Idera for $6 million in transaction-related expenses as a result of terminating the merger agreement, which was announced in January. As of Tuesday’s close, BioCryst shares had advanced 9.8% since the January announcement, while Idera shares had fallen 46%.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.